Identification low molecular weight inhibitor osteoblast mitogenesis uremic plasma low molecular weight inhibitor cartilage sulfation plasma dialysis patients Preliminary studies inhibitor role bone mass bone cell proliferation vitro bioassay crude sulfation inhibitor preparations nonspecific inhibitor osteoblast mitogenesis uremic plasma plasma plasma ultrafiltrates dialysis patients gel filtration chromatography inhibition mitogenesis cultured osteoblasts Material fractions molecular weight range osteoblast mitogenesis inhibitory effect serum insulin-like growth factor-I mechanism inhibition growth factor dependent Further characterization inhibitor peptide polar lipid uremic plasma bone cell mitogenic inhibitor role bone adults bone growth children 